Thyroid Hormone Receptor alpha-1 Directly Controls Transcription of the beta-Catenin Gene in Intestinal Epithelial Cells by Samarut, Jacques et al.
Thyroid Hormone Receptor alpha-1 Directly Controls
Transcription of the beta-Catenin Gene in Intestinal
Epithelial Cells
Jacques Samarut, Michelina Plateroti, Elsa Kress, Jun Ichirou Mori
To cite this version:
Jacques Samarut, Michelina Plateroti, Elsa Kress, Jun Ichirou Mori. Thyroid Hormone Re-
ceptor alpha-1 Directly Controls Transcription of the beta-Catenin Gene in Intestinal Epithe-
lial Cells. Molecular and Cellular Biology, American Society for Microbiology, 2006, 26 (8),
pp.3204-3214. <ensl-00000005>
HAL Id: ensl-00000005
https://hal-ens-lyon.archives-ouvertes.fr/ensl-00000005
Submitted on 7 Apr 2006
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
MOLECULAR AND CELLULAR BIOLOGY, Apr. 2006, p. 3204–3214 Vol. 26, No. 8
0270-7306/06/$08.000 doi:10.1128/MCB.26.8.3204–3214.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Thyroid Hormone Receptor 1 Directly Controls Transcription
of the -Catenin Gene in Intestinal Epithelial Cells†
Michelina Plateroti,1* Elsa Kress,1 Jun Ichirou Mori,1 and Jacques Samarut1,2
IFR 128, Laboratoire de Biologie Mole´culaire de la Cellule, Biosciences,CNRS UMR 5161, INRA UMR 1237, Ecole Normale Supe´rieure
de Lyon, Lyon, France,1 and Universite´ Claude Bernard Lyon 1, Lyon, France2
Received 29 July 2005/Returned for modification 30 September 2005/Accepted 17 January 2006
Thyroid hormones, T3 and T4, are known regulators of intestine development. The best characterized
example is the remodeling of the gastrointestinal tract during amphibian metamorphosis. Thyroid hormones
act via nuclear receptors, the TRs, which are T3-dependent transcription factors. We previously showed that
intestinal epithelial cell proliferation is controlled by thyroid hormones and the TR gene. To analyze the
mechanisms responsible, we studied the expression of genes belonging to and/or activated by the Wnt/-catenin
pathway, a major actor in the control of physiological and pathological epithelial proliferation in the intestine.
We show that T3-TR1 controls the transcription of the -catenin gene in an epithelial cell-autonomous way.
This is parallel to positive regulation of proliferation-controlling genes such as type D cyclins and c-myc, known
targets of the Wnt/-catenin. In addition, we show that the regulation of the -catenin gene is direct, as TR
binds in vitro and in chromatin in vivo to a specific thyroid hormone-responsive element present in intron 1
of this gene. This is the first report concerning in vivo transcriptional control of the -catenin gene. As
Wnt/-catenin plays a crucial role in intestinal tumorigenesis, our observations open a new perspective on the
study of TRs as potential tumor inducers.
The mammalian gut develops from the association of the
endoderm and the splanchnic mesoderm. The adult features
are acquired during well-defined fetal and postnatal develop-
mental steps, which are completed at the weaning (16, 18). The
pluristratified gut endoderm is remodeled to form a monolayer
of rapidly renewing columnar epithelial cells, organized in the
small intestine in the typical finger-shaped structure (49).
From a functional point of view, this defines specific spatial
and functional units: the villi, which constitute the differenti-
ated compartment, and the crypts of Lieberku¨hn, where pro-
liferation takes place. The main characteristic of the intestinal
epithelium is its continuous cell renewal, which is fuelled by
multipotent stem cells within the crypts (49). The rate of crypt
cell division, migration, and villus cell differentiation must be
tightly controlled to ensure epithelial homeostasis (49).
Several pathways have been described to play an important
role in the control of epithelial proliferation in the intestine,
during early development as well as during the continuous
renewing in adulthood (3, 49). Among these pathways, the
Wnt/-catenin pathway has received major attention, as it is
involved in the normal and in the pathological proliferation of
the gut (4, 50). The signal transducing components of the Wnt
pathway are receptors belonging to the frizzled and LRP pro-
tein families (35, 42). One target of the Wnt pathway is the
-catenin protein. In the absence of Wnt signal, -catenin is
destabilized by phosphorylation from a cytoplasmic complex
comprising axin, adenomatous polyposis coli, and glycogen
synthase kinase 3. The phosphorylated -catenin is finally
degraded by the proteasome. The action of this complex can be
antagonized by disheveled, a cytoplasmic protein that is acti-
vated by the frizzled receptors. In addition to Wnt, some other
factors have been shown to act in the stabilization of -catenin,
such as insulin-like growth factor, epidermal growth factor, and
human growth factor, through their respective thyrosin kinase-
associated receptors (35). The main characteristic of the sta-
bilized -catenin is its accumulation in the cytoplasm and mi-
gration into the nucleus, where it acts as a transcriptional
coactivator by associating with transcription factors of the Tcf/
Lef family (35). Intestinal tumors characterized by actively
proliferating cells display high levels of nuclear -catenin (42).
Recently, van de Wetering et al. (52) described the presence of
-catenin in the nuclei of crypt cells, strongly supporting its
role in the control of cell proliferation. The complex -catenin/
Tcf has been shown to control the expression of several genes
involved in cell cycle/proliferation control like cyclin D1, c-
myc, and cdx1 (54) as well as, indirectly, cyclin D2 (20). It is
worth noting that mutations of the different partners of this
pathway are responsible for tumorigenesis in humans, as they
constitutively activate uncontrolled cell proliferation (42, 50).
In fact, activation of this pathway as well as that of the ras
oncogene are sufficient to induce colon tumorigenesis (3). Sur-
prisingly, to date, very little is known on the transcriptional
regulation of the -catenin gene.
Several observations suggested that thyroid hormones (TH),
T3 and T4, are involved in the control of intestinal develop-
ment (15). First of all, it has been shown that the gastrointes-
tinal tract remodeling during amphibian metamorphosis is
completely dependent on TH (48). In rodents, they have been
shown to participate in the developmental processes responsi-
ble for the increase in the mucosa growth as well as in the onset
of the adult-type digestive enzymes of the absorptive entero-
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cytes at weaning (15). The action of TH is mediated by T3
binding to thyroid hormone nuclear receptors, the TRs, which
belong to the nuclear hormone receptor family of transcription
factors (21). The TRs are encoded by two genes, TR and TR
(22), each of which produces several protein isoforms (10).
More recently, using congenital hypothyroid and TR knockout
mice, we pointed out that TH act on the intestinal postnatal
development mainly through the control of the proliferation of
the intestine epithelial progenitor cells. This function depends
on the TR1 receptor (9, 13, 41).
To analyze the molecular targets of T3-activated TR1 in
the intestine, we focused here on the regulation of the Wnt/-
catenin pathway. We showed that T3-TR1 controls the ex-
pression of the murine -catenin gene, catnb, by binding on the
chromatin of epithelial cells to a functional TRE sequence in
intron 1. This effect is parallel to the activation of the Wnt/-
catenin target genes, including type D cyclins and c-myc. This
work then provides the first demonstration of the direct control
of transcription of the -catenin gene.
MATERIALS AND METHODS
Animal treatment and tissue preparation. TR0/0 (13), TR/ (12), Pax8/
(28), and the respective wild-type animals have been used in this study. Mice
were housed and maintained with approval from the animal experimental com-
mittee of the Ecole Normale Supe´rieure de Lyon (Lyon, France). TH deficiency
in pups was induced by feeding the mothers a low-iodine diet supplemented with
0.15% propylthiouracil (PTU; Harlan/Teklad) for 2 weeks. To induce TH defi-
ciency in adult animals, they were fed the low-iodine diet supplemented with
0.15% PTU and 0.05% methimazole (Sigma) in the drinking water for 3 weeks.
Hyperthyroidism was induced by intraperitoneal injections of a mixture of T4
and T3 (2.5 mg/kg T4 and 0.25 mg/kg T3 in 100 l of phosphate-buffered saline)
for the indicated length of time. Control animals were fed standard mouse chow.
Animals were sacrificed at the indicated ages, and the intestine was quickly
removed. The proximal and distal parts of the small intestine were fixed in 10%
buffered formalin for immunohistochemistry or frozen in liquid nitrogen and
used for RNA and/or protein extraction. Blood was also recovered for serum
preparation, and the levels of free T3 and T4 were analyzed by a VIDAS
enzyme-linked assay kit (Biomerieux). The data on T3 and T4 measurements are
reported in Tables S1 and S2 in the supplemental material.
Primary cell culture of intestine epithelial cells. Primary intestinal cell cultures
were derived from 10-day postnatal mice. After sacrifice, the whole small intes-
tine was removed. The epithelium was isolated as intact organoids by enzymatic
dissociation using collagenase type XI (Sigma) and dispase (Boehringer Mann-
heim) followed by physical disaggregation (8). Organoids were plated in Dul-
becco’s modified Eagle medium (DMEM; Invitrogen) supplemented with 2.5%
heat-inactivated fetal calf serum (Gibco) depleted of T3 and T4 (45), 20 ng/ml
epidermal growth factor (Sigma), and insulin-transferrin-selenium diluted 1/100
(Sigma). Cultures were maintained on 24-multiwell tissue culture dishes. For
immunolabeling experiments, coverslips were inserted in the wells. Culture sur-
faces were coated with type 1 collagen. The purity of the epithelial colonies was
analyzed by immunolabeling for specific markers: epithelial cells by anticytok-
eratins (ICN); fibroblasts by antivimentin (Sigma); smooth muscle cells by anti-
smooth muscle actin (Sigma). Cells were analyzed after 5 days of culture. For the
analysis of T3 action in vitro, 107 M T3 or vehicle alone was added to the
culture medium for the indicated length of time. Cycloheximide (15 g/ml) was
added as indicated. For proliferation studies, 10 M bromodeoxyuridine (BrdU)
was added to the culture medium during an overnight incubation.
RNA extraction and analysis. RNA was extracted from tissues using the
QIAGEN RNeasy kit (QIAGEN) and from cell cultures using the Stratagene
Absolutely RNA nanoprep kit (Stratagene). To avoid the presence of contami-
nating DNA in RNA samples, DNase digestion (according to the specific in-
structions of the manufacturer; QIAGEN or Stratagene) was performed in all
preparations. Northern blot analysis was carried using a Hybond N membrane
(Amersham), and DNA probes for -catenin, cyclin D1, cyclin D2, c-myc, and
hypoxanthine phosphoribosyltransferase (HPRT) were labeled by random prim-
ing using [32P]ATP. Real-time quantitative PCR analysis used random hexa-
nucleotide priming and amplification in a Lightcycler apparatus (Bio-Rad Lab-
oratories) using SYBR green PCR master mix according to the manufacturer’s
instructions (QIAGEN). The primers used are listed in Table S3 in the supple-
mental material. The data from the PCR were normalized to that of 36B4 levels
in each sample. Semiquantitative reverse transcription (RT)-PCR was used to
analyze TR1 expression; HPRT has been used as internal control. The primers
were as follows: TR1, 5-GGAGATGATTCGCTCACTGCAG and 5-CGACTT
TCATGTGGAGGAAG (product size, 720 bp); HPRT, 5-GCTGGTGAAAAGG
ACCTCT and 5-CACAGGACTAGAACACCTGC (product size, 240 bp).
Cell line culture and transfection. Cos1 cells were cultured in DMEM sup-
plemented with 5% heat-inactivated fetal calf serum. The different constructs
were cloned in the pGL2 basic expression vector (Promega). The wild-type or
mutated 36 bp of the catnb gene comprising TRE-int1 (from bp 2140 to 2175 of
intron 1) were cloned upstream of a simian virus 40 minimal promoter (29). The
cells were transfected using the Exgen transfection reagent (Euromedex). After
transfection, cells were maintained in thyroid hormone-depleted serum (45). T3
(107 M) or vehicle alone was added to the culture medium 24 h before the end
of the culture. Luciferase activity was measured 48 h after transfection using the
luciferase dual system (Promega).
Electrophoretic mobility shift assay (EMSA). (i) In vitro protein synthesis.
Full-length cDNA cloned in pSG5 (Stratagene) coding for mouse TR1, rat
TR1, and mouse RXR were transcribed/translated in vitro using the TNT kit
(Promega). Each cDNA was under the control of the T7 promoter.
(ii) EMSA. The single-strand oligonucleotides were labeled with T4 polynu-
cleotide kinase (Fermentas) in the presence of [-32P]ATP. After annealing with
the complementary cold oligonucleotides, the probes were purified on a 10%
acrylamide gel and the specific bands were eluted overnight at 4°C in Tris-
EDTA. Binding reactions were performed for 20 min using the radiolabeled
DNA probes (20,000 cpm) and the in vitro-transcribed TR and/or RXR in 10%
glycerol, 10 mM HEPES, 30 mM KCl, 4 mM spermidine, 0.1 mM EDTA, 0.25
mM dithiothreitol, 1 mM Na2PO4, and poly(dI-dC) (1.5 g). Unlabeled specific
and nonspecific competitor oligonucleotides were included at the indicated mo-
lar excess in the binding reactions. Where indicated, anti-TR1 antibodies (anti-
bodies raised against a C-terminal peptide and affinity purified with the same
peptide) have been included in the reaction mix for 30 min on ice. After binding,
reaction samples were loaded on a 5% nondenaturing polyacrylamide gel and
electrophoresed for 2 h at 180 V, followed by gel fixation, drying, and exposure
to X-ray film.
Western blot and immunolabeling. Whole-protein extracts were obtained by
homogenizing mouse intestine in 5 mM HEPES (pH 7.9), 26% glycerol, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl
fluoride. NaCl was added to a final concentration of 300 mM before centrifuga-
tion. Supernatant proteins were separated on a 10% acrylamide–bis acrylamide
(29:1) gel and transferred to a nitrocellulose membrane (Hybond ECL) before
incubation with the first antibody. This was followed by an incubation with
secondary anti-rabbit or anti-mouse immunoglobulin G–horseradish peroxidase
(Promega). The signal was analyzed by using the enzymatic chemiluminescence
detection kit (Amersham).
Antibodies. We used the following primary antibodies: mouse monoclonal
anti-cyclin D2 (Sigma), rabbit anti--catenin (Santa Cruz), mouse anti-cyclin D1
(Santa Cruz), rabbit anti-c-myc (a gift from Calame Kathryn, Columbia Univer-
sity College of Physicians and Surgeons, New York), and mouse anti--actin
(Sigma). Immunohistochemical analysis of -catenin (Santa Cruz), TR1 (anti-
bodies raised against a C-terminal peptide and affinity purified with the same
peptide), and Ki67 (Novocastra) was performed on 10% buffered formalin-fixed
paraffin-embedded tissue sections. Immunolabeling for -catenin and BrdU
(Roche) has been done on 2% paraformaldehyde fixed cell cultures. Secondary
fluorescent antibodies were from Jackson Laboratories. Confocal analysis has
been performed on a Zeiss Axiovert microscope, with fluorescence microscopy
on a Zeiss Axioplan microscope.
ChIP and DNA analysis. The chromatin immunoprecipitation (ChIP) study
was performed on collagenase-dispase-separated epithelial fragments from 3- to
5-day-old mouse intestines. The monolayer of cells was incubated with 1%
formaldehyde in DMEM for 5 min at 37°C. The reaction was blocked by the
addition of glycine to a final concentration of 125 mM, followed by two washes
of cold phosphate-buffered saline (Invitrogen) containing protease inhibitors
(Roche). ChIP was conducted using the kit from Upstate according to the
manufacturer’s instructions. Briefly, 500 ng of sonicated DNA (fragments of 200
to 1,000 bp, by using a Vibra Cell by Sonics and Materials, Inc.) were incubated,
respectively, with 10 l of anti-TR1, anti-TR1 (Affinity Bioreagents), and
preimmune sera overnight at 4°C. At the end of the reaction and washing steps,
DNA was extracted by phenol-chloroform and suspended in 30 l of H2O. Four
microliters of samples was used for conventional PCR (Taq from Eurogentec).
For quantitative PCR we used the Lightcycler apparatus (Bio-Rad Laboratories)
and the SYBR green PCR master mix from QIAGEN. The primers are listed in
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Table S4 in the supplemental material. All of the amplified fragments have been
controlled by cloning and sequencing.
RESULTS
TR gene controls gut epithelial proliferation starting early
after birth. Our previous study indicated the major involve-
ment of the TR gene in the control of epithelial proliferation
in the intestine during weaning time (40, 41). We extended
here this observation and analyzed the rate of cell proliferation
in the TR0/0 knockout mice (13) compared to the wild type
(WT) throughout fetal and postnatal intestinal development
until adulthood (Fig. 1A). In TR0/0 mutants, we observed a
25% decrease in the number of proliferating cells at postnatal
day 1 and in 8-week-old adult animals and a decrease of nearly
50% at 7, 14, and 21 days after birth compared with the re-
spective WT animals. This was observed in both the proximal
(Fig. 1A) and distal small intestine (not shown). Looking for
the expression of the TR1 receptor, we could observe that
TR1 mRNA was expressed during this same period (Fig. 1B).
Moreover, TR1 protein, analyzed by an immunohistochemi-
cal approach, was specifically present in the crypt cells, as
shown for the 14-day-old intestine (Fig. 1C to H; see Fig. S1C
to H in the supplemental material).
Thyroid hormone controls the expression of the Wnt/-cate-
nin pathway. Focusing on 2-week-old animals, we studied the
expression of several components of the Wnt pathway, includ-
ing -catenin; -catenin destabilizers adenomatous polyposis
coli, glycogen synthase kinase 3, and axin; -catenin stabilizer
disheveled; -catenin transcription cofactor TCF4 and its re-
pressors Groucho and Chybby (1, 51). Using RNAs extracted
from euthyroid, hypothyroid, and hyperthyroid intestines, we
observed that the expression of these genes was unaffected by
the TH status (not shown), except for -catenin. In fact, chem-
ical-induced or congenital hypothyroidism resulted in a de-
crease of -catenin mRNA and protein (Fig. 2A and B). TH
injections for 2 days resulted in an increase of both mRNA and
protein levels. We also analyzed the expression of the down-
stream targets of this pathway, cyclin D1 and c-myc (1), as well
as the indirect target cyclin D2 (20), in animals of different TH
status (Fig. 2A and B). All of these genes, expressed mainly in
crypt cells where they control the cell proliferation (5, 25, 52),
showed a decreased expression at the mRNA and protein
levels in hypothyroid conditions and a strong increase after TH
injection.
We then analyzed the kinetic profile of mRNA induction to
clarify the hierarchy of the gene induction. We gave a single
pulse of TH to hypothyroid animals and recovered the intes-
tine at different time points: 1 h, 3 h, 5 h, and 7 h after
injection. The results are illustrated in Fig. 2C. Cyclins D1 and
D2 and c-myc (not shown) mRNA expression were not
changed over a period of 7 h after injection (Fig. 2C). On the
contrary, -catenin mRNA started to be increased as early as
1 h after TH injections, being statistically significant after 3 h
and reaching a maximum level 5 h after the injection (Fig. 2C).
These data indicate that -catenin induction by TH is an ear-
lier event than with the other studied genes.
We also quantified -catenin mRNA and protein expression
in TR and TR mutant mice having different TH status to
evaluate whether TH responsiveness depended on a specific
TR pathway (Fig. 2D and E). Wild-type and TR / animals
showed a decreased -catenin mRNA and protein expression
under hypothyroid conditions and an induction after TH treat-
ment for 6 h (not shown) or 2 days. Untreated TR0/0 mice,
which showed a decreased level of -catenin mRNA compared
to wild-type mice under the same conditions, displayed un-
changed levels of this mRNA and protein under hypothyroid
or hyperthyroid conditions. Similar analysis was performed on
wild-type and TR0/0 adult animals. The results showed that
-catenin gene and protein expression was regulated in a sim-
ilar manner in the adult and the developing intestine (see Fig.
S2A and B in the supplemental material). The parallel analysis
of the downstream controlled gene cyclin D1 at the mRNA
(not shown) and protein levels (Fig. 2E; see Fig. S2B in the
supplemental material) showed a trend of regulation similar to
that of -catenin. It is worth pointing out that both -catenin
and cyclin D1 expression are much more affected by hypothy-
roidism than by lack of the TR gene (compare wild-type PTU
with TR0/0). This is probably due to the aporeceptor effect of
the nonliganded TR1 in the absence of T3 (9). Altogether,
these data demonstrated that the regulation of -catenin ex-
pression by TH depended specifically on the TR1 receptor in
the developing and the adult intestine.
In vitro analysis of the -catenin induction by thyroid hor-
mone and TR gene. To analyze a homogeneous cell popula-
tion and to understand whether the responsiveness to TH
through the TR gene is an epithelial cell autonomous pro-
cess, we used a model of epithelial primary cultures from WT
and TR knockout mice. The enzymatic separation between the
epithelium and the connective tissue (8) provided a highly pure
epithelial cell population (see Fig. S3 in the supplemental
material). BrdU incorporation analysis showed that this cul-
ture system preserved a population of proliferating cells, pre-
sumably epithelial progenitors. However, due to the small size
of the epithelial organoids, this model could only be used for
immunolabeling and quantitative real-time RT-PCR experi-
ments.
First, we tested whether the cell proliferation in vitro was
affected by the addition of T3 in the culture medium (Fig. 3A).
Primary cultures established from WT as well as TR/ in-
testine showed a strong increase in the rate of BrdU-positive
cells when maintained for 2 days in the presence of T3 com-
pared with untreated cells. In contrast, TR0/0-derived cell
cultures showed a lower level of proliferating cells than the WT
and did not respond to T3 treatment.
The in vitro model was then used to analyze specific gene
expression by quantitative real-time RT-PCR. We studied
-catenin expression in vitro in control or T3-treated cells for
different lengths of time (Fig. 3B). The mRNA level increased
after T3 treatment, reaching statistical significance after 6 h. In
vivo studies showed a hierarchy in the induction of gene ex-
pression by TH. If the induction of the Wnt/-catenin target
genes by T3-TR1 depends on the previous induction of the
-catenin, the use of in vitro model could help to answer to this
question. For this reason, we treated the cells with cyclohexi-
mide and/or T3 for 24 h and analyzed the expression of -cate-
nin and cyclin D1. In non-cycloheximide-treated cells, we ob-
served an induction of both mRNAs compared to the control
(Fig. 3C). The addition of cycloheximide specifically sup-
pressed the induction by T3 of cyclin D1 expression. On the
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FIG. 1. Analysis of crypt cell proliferation and TR1 expression in the small intestine. (A) Study of cell proliferation during development in
the proximal small intestine. Ki67 immunolabeling was performed as previously described (41). The number of Ki67-positive nuclei has been
evaluated on well-oriented sections from 4 to 5 different animals per age. Histograms represent means  standard deviations. Statistical analysis
was conducted by using two-tailed Student t test. , P 	 0.05; , P 	 0.001. P, postnatal day; W, weeks. (B) Analysis of TR1 expression by
semiquantitative RT-PCR during intestine development. HPRT was used as an internal control. E, embryo; PN, postnatal. (C to H) TR1 protein
immunolabeling (E and H) on a 2-week-old mouse intestine. In panel C, the phase-contrast picture is shown. All nuclei were stained with Hoechst
(D). In panels F and G, the merging of each simple staining is shown. Controls for TR1 antibody specificity are illustrated in Fig. S4 in the
supplemental material. Bars, 15 m (C to F); 7 m (G and H). Abbreviations: ve, villus epithelium; ce, crypt epithelium. The white dotted bar
defines the limit between the crypt and the villus compartments. Some villi (red dots) and crypts (yellow dots) are highlighted in panels C to E.
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contrary, cycloheximide had no effect on -catenin up regula-
tion by T3 (Fig. 3C). The small decrease of gene expression in
the cycloheximide-treated cells is probably due to a general-
ized action of the drug. These data demonstrate that the pos-
itive regulation of the -catenin gene expression does not need
protein synthesis, strongly suggesting a direct effect on -cate-
nin but not on the cyclin D1 gene.
Characterization of a functional TRE in intron 1 of the
-catenin gene: in vitro and in vivo studies. The data on the
regulation of -catenin gene by TH and TR1, in vivo and
in vitro, suggested that this gene may be a direct target of
the TR1 receptor. Looking in silico for prediction of TRE
sequences in the mouse -catenin gene catnb, we found a
sequence of 36 bp (referred as TRE-int1), spanning from
FIG. 2. Study of TH action in vivo. (A) Representative Northern blot analysis of the indicated mRNAs in 2-week-old intestine of euthyroid
(Pax8/) (Ctr), congenital hypothyroid (Pax8/) (Hypo), and hyperthyroid (Pax8/ TH-injected) (Hyper) animals. HPRT mRNA was used as
an internal control. (B) Representative Western blot analysis of indicated proteins in animals as described for panel A. (C) Kinetic analysis of gene
induction by TH evaluated by Northern blotting. PTU-treated animals were injected with TH for the indicated time. 18S RNA was the internal
control. Histograms (means  standard deviations) summarize densitometry analyses from three independent experiments. (D) Quantitative
real-time RT-PCR analysis of -catenin mRNA in intestines of TR0/0, TR /, and WT animals displaying different TH status. The picture is
representative of two independent experiments, with 3 animals/condition. Histograms represent means  standard deviations. (E) Representative
Western blot analysis of indicated proteins in animals as described for panel D. Statistical analysis was conducted by using two-tailed Student t test.
, P 	 0.001. C, control; P, PTU treated; T, TH injected (inj).
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nucleotide 2140 of the first intron and containing four pu-
tative TRE sites (Fig. 4A). While the TRE-A is a perfect
DR4 (6), the sites TRE-B, TRE-C, and TRE-D show de-
generate DR4 structures. To evaluate whether the TR1 re-
ceptor binds in vitro to these TREs, we performed EMSAs. Com-
pared to a synthetic positive control DR4 (29), the TRE-int1 has
the same ability to bind to TR1 as a monomer, homodimer,
and TR1/RXR heterodimer (Fig. 4C and D). These com-
plexes were supershifted after incubation with an antibody
against TR1 (Fig. 4D). We also tested by EMSA different
mutant TRE-int1 sequences (Fig. 4B). Mutant 2,5, mutant 6,
and to a lesser extent, mutant 3 retained their ability to bind to
TR1 as a monomer, homodimer, and heterodimer (Fig. 4E).
Mutant 1,4 had a lower ability, and mutant 2,3,4 was unable to
bind to TR1.
Next, we analyzed the enhancer properties of the -catenin
TREs in transient-transfection experiments. We cloned the
36-bp TRE-int1 sequence upstream of a minimal simian virus
40 promoter (29) in a luciferase reporter vector and then
transfected it in Cos1 cells (Fig. 5). The expression of the
luciferase was analyzed in the presence or absence of either
TR1 expression vector and/or T3. As Cos1 cells contain low
levels of endogenous TR1, induction of the DR4 positive
control by T3 was observed only in cultures cotransfected with
the TR1 expression vector. A similar response was observed
with the TRE-int1 reporter, showing that it is functionally
responsive to T3. When we compared the different TRE-int1
mutant constructs, it was clear that only those preserving the
TRE-A, alone or in combination with TRE-B and C, displayed
a responsiveness to T3 similar to that of the TRE-int1. Alto-
gether, these data strongly suggested that TRE-A is the func-
tional binding site for TR1.
To check whether the TRE-int1 is a binding site for TR1
in vivo, we investigated the binding by in vivo ChIP assay.
We performed these experiments on collagenase-dispase-
isolated fragments of the intestinal epithelium, freshly pre-
pared from newborn animals. Figure 6 summarizes the set
up and the results of these experiments. The sonicated chro-
matin has been incubated with anti-TR1, anti-TR1, or
preimmune sera. The precipitated DNA from these differ-
ent experimental conditions and in the starting inputs was
then analyzed by conventional and real-time PCR to reveal
the presence of specific DNA templates. All of the amplified
products have been controlled by cloning and sequencing
(not shown). Interestingly, using the Catnb1 and Catnb2
primers, which amplify DNA fragments of the catnb gene,
including the TRE-int1 (Fig. 6A), we showed a specific band
only in the samples incubated with the anti-TR1 antibody
(Fig. 6B, lane b). A band of the same size was obviously
present in the starting input samples (Fig. 6B, lane d). To
verify the specificity of this result, we performed a PCR
analysis using the Catnb3 and Catnb4 primers, which am-
plify fragments of the intron 1 outside the TRE (Fig. 6A).
Moreover, we used primers specific to promoters of the
phosphoriboprotein gene 36B4 and of the villin gene, for
which no regulation by TH has been described. Using these
oligonucleotides, we only amplified DNA fragments in the
starting inputs (Fig. 6B, lanes d), indicating that the anti-
TR1 antibody does not bind the chromatin aspecifically.
To quantify the amount of the DNA precipitated by the
FIG. 3. In vitro study of TH action. (A) Rate of cell proliferation in
epithelial primary cultures from WT and TR knockout intestines, after
BrdU incorporation and immunolabeling. Total nuclei stained with
propidium iodide and BrdU-positive nuclei were counted under the
microscope. Histograms (means  standard deviations) represent re-
sults from three independent experiments conducted (each) on 12
1-cm wells. (B) -Catenin mRNA quantification by real-time RT-PCR,
evaluated at different times of T3 treatment. The results (means 
standard deviations) are the summary of those for four independent
experiments, each conducted in duplicate. (C) -Catenin and cyclin D1
mRNA expression in primary cultures maintained during 24 h in the
presence () or absence () of T3 and/or cycloheximide (Cyclohex).
Data (means  standard deviations) summarize the results of two
independent experiments conducted in triplicate. Two-tailed Student
t test was used. , P 	 0.05; , P 	 0.001; , P 	 0.0001.
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TR1 antibodies, we also performed real-time PCR. Using
the Catnb1 (Fig. 6C) and Catnb2 (not shown) primers, we
amplified specific DNA fragments. The amounts are ex-
pressed as percentages of the starting inputs. No specific
amplification could be observed in the samples incubated
with the anti-TR1 or preimmune sera or in the different
samples when we used the Catnb3 (Fig. 6C), Catnb4, and
p36B4 (not shown) primers. These data clearly demon-
strated that, in intestinal epithelial cells in vivo, TR1 binds
to the -catenin gene at the level of the TRE-int1.
DISCUSSION
In this paper and in previous reports, we pointed out that
T3-activated-TR1 receptor controls the proliferation of the
intestinal epithelial cells in vivo and in vitro. In an attempt to
identify the molecular basis of this control, we focused here on
the analysis of the Wnt/-catenin pathway, since it plays a
central role in the control of normal and pathological cell
proliferation in the gut (42). Interestingly, we observed that the
TR1 receptor directly controls the transcription of the -cate-
FIG. 4. Molecular analysis of the thyroid hormone responsive element present in the catnb gene. (A) Structure of the four putative DR4 found
in intron 1. Divergences from canonical DR4 are indicated in boldface type. (B) WT TREint-1, showing the GT sequences (1 to 6) substituted in
the different TRE mutants. (C to E) EMSA analysis using the labeled probes indicated and in vitro-transcribed/translated proteins indicated. The
specificity of the binding was assessed by adding specific or nonrelated cold sequences at the indicated molar excess (Comp. 10
 or Comp. 100
).
, present; , absent.
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nin gene, the central actor of this pathway. In fact, in vivo and
in vitro models treated with TH displayed an increase in
-catenin mRNA and protein expression. This was parallel to
the up-regulation of cyclins D1 and D2 and c-myc, well-known
proliferation controlling genes (5, 25, 52) and targets of the
Wnt/-catenin pathway (1, 20). Several findings support the
assertion that the -catenin gene, but not cyclin D or c-myc, is
directly regulated by TH. First, induction of the -catenin
mRNA in vivo and in vitro is achieved after a short time of
treatment by TH. Second, the cycloheximide addition to the
culture medium does not prevent the up-regulation of the
-catenin mRNA in vitro by T3, as it is the case for cyclin D1
mRNA. Third, TH injections to TR0/0 animals, which are
unable to stimulate -catenin expression, also fail to increase
the cyclin D1 mRNA compared to the WT animals (data not
shown). Finally, we also provided the experimental proof that
in epithelial cells of the intestine in vivo, TR1 is fixed on the
TRE-int1 present in the catnb gene. This is the first report of
in vivo ChIP analysis which shows the occupancy of a TRE by
a TR receptor in mammals. A binding of TRE by TRs has
already been reported for Xenopus laevis target genes (44).
The regulation of the transcription of the -catenin gene by
T3 is likely to go through the TRE-int1. In fact, it is the unique
responsive element found within the promoter environment.
Moreover, its intronic location is not surprising, since several
reports described TREs located downstream of the promoters
(7, 38, 46). We also showed that the TRE-int1 is composed of
several TREs organized in tandem, reminiscent of the TREs
present in the rat growth hormone gene (37).
Despite the well-described posttranslational control of the
-catenin, very little is known at the gene transcription level. A
recent paper described the cloning and analysis of the rat and
human -catenin regulatory regions of this gene (23). Inter-
estingly, several AP1 binding sites and one TCF binding site
have been described, suggesting that several putative factors
may influence the transcription of this gene. However, no phys-
iological functions for these regulatory regions have been re-
ported until now. We showed here that the TRE in intron 1 of
the catnb gene is functional in vivo and in vitro.
-Catenin is a central actor in gut epithelial cell homeosta-
sis, and its subcellular localization defines specific functions in
cell adhesion (membrane bound) or in target gene activation
(nuclear presence) (36, 52). We reported in our study that TH
deprivation or supplementation in animals and in cells affects
-catenin gene and protein expression. More specifically, TH
treatment allows an increase of its levels. The availability of
free -catenin, which migrates into the nuclei, is controlled by
several mechanisms involving stabilizing and destabilizing
phosphorylations as well as destabilizing dephosphorylations
(36). In TH-stimulated models, we observed an increase of
-catenin-positive nuclei (not shown), strongly suggesting that
this treatment positively affects its stabilization. However, the
exact mechanisms responsible for this remain to be clarified
and will be the subject of future investigations.
In the nucleus, -catenin activates the transcription of target
genes, as it binds to the Tcf/Lef family of transcription factors
(35). Here we show that some of its targets, activators of cell
proliferation, are positively regulated by TH in vivo and in
vitro. This strongly suggests that the increase of cell prolifer-
ation induced by TH may be dependent on the activation of
FIG. 5. Transient-transfection analysis in Cos1 cells. Two hundred nanograms of the luciferase expression vector was transfected alone or in
combination with 200 ng of pSG5-hTR1 expression vector. Cells were treated or not with 107 M T3 for 16 h. Bars represent means  standard
deviations (n  6).
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-catenin expression. Is the increase of the -catenin expres-
sion per se sufficient to induce cell proliferation? This is a
crucial question. Several reports indicated that increasing the
level of -catenin leads to increased cell proliferation in vari-
ous systems, such as the intestine (47, 55), liver (32, 34), and
vestibular cells (19). This strongly supports our own data show-
ing that the increase of -catenin expression is one key molec-
ular event related to the activation of cell proliferation. How-
ever, it is worth pointing out that a negative control by TH of
the Wnt pathway was described in an in vitro model of pituitary
cells (33). In this model, the positive action of the TH on cell
proliferation was parallel to a decrease of -catenin expres-
FIG. 6. In vivo ChIP. (A) Scheme of intron 1 of the catnb gene displaying the different primers used for this study. S (sense) and AS (antisense)
numbers refer to oligonucleotide primers of the respective Catnb-amplified fragment numbers. E1 and E2 refer to exons 1 and 2, respectively. The
arrow upstream of E1 indicates the promoter of the gene. Note that Catnb1 and Catnb2 primers amplify DNA fragments comprising the TRE.
Catnb3 and Catnb4 were used as negative controls, as the amplified fragments are, respectively, 500 bp and 3,000 bp away from the TRE. (B) Study
by conventional PCR of the DNA purified from the different samples before and after ChIP. The picture is representative of the results from two
independent experiments. On the right part of each panel, the fragment amplified on the catnb gene or on the promoters of 36B4 and villin genes
is indicated: a, preimmune serum; b, anti-TR1; c, anti-TR1; d, starting input; e, negative control for PCR mix. (C) Quantitative real-time PCR
study of the purified DNA before and after ChIP. The amount of the indicated products is illustrated as a percentage of that measured in the
starting inputs. The picture is representative of the results of two independent experiments.
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sion. However, there was no indication of a direct negative
control of the -catenin gene by TRs in these cells. The dif-
ferent model systems analyzed and differences in the cellular
and molecular microenvironment may account for the discrep-
ancy with our results. It is worth pointing out that our results
are consistent with the well-established fact that the Wnt/-
catenin pathway is a positive regulator of the intestine cell
proliferation.
Our observations suggested that TH signaling in the intes-
tine is essential throughout intestine development and in adult-
hood. However, a major role is played during postnatal devel-
opment, when an extensive growth takes place (39). Indeed,
this period also corresponds in the mouse to a surge of TH,
which declines starting from the third week to reach a steady-
state adult level (14). According to this, TR knockout mice
show more intestinal impairment during the first 3 weeks after
birth than in adulthood. Moreover, the absence of TH produc-
tion during early postnatal development, as in the congenital
hypothyroid Pax8/ mice (28), has dramatic effects on intes-
tine development, much more so than in TR mutants (9).
This can be explained by the aporeceptor function of TR1 in
absence of TH, acting as a transcription repressor of target
genes (9, 26). In this light, the repression of -catenin and of its
downstream targets observed in hypothyroid animals (both
congenital and chemical induced), may help explain some
traits of the intestine phenotype. Indeed, removal of the TR1
receptor in Pax8/ animals was previously reported to induce
a recovery of intestine development (9).
Together, these data indicated that T3-activated TR1 plays
an essential role in postnatal intestine development as well as
in adult homeostasis. Our present data show that the action on
the -catenin gene control is one of the molecular processes
involved.
Until now few studies pointed to a function of TH and TR
in gastrointestinal physiopathology (11, 15, 17, 27, 31). Some
data showed a correlation between altered levels of TH and
the incidence of breast and colon cancer in humans (43). On
the other hand, it has been reported that hyperthyroxinemia
can influence the rate of colon cancer in an experimental
model of carcinogenesis in rats (24). Finally, in some cases, the
absence (30) or the mutation (53) of the TRs have been asso-
ciated with gastrointestinal tumors. In our study, we show that
TH and TR1 receptor control epithelial cell proliferation and
the expression of components of the Wnt pathway. As -cate-
nin and some of its target genes are involved in intestinal
tumorigenesis, our data open new perspectives in the function
of the TR1 receptor as a potential tumor inducer, as is the
case for other nuclear receptors (2).
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